Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden
Annals of Translational Medicine · 2026-06 · 14 (3) · 31-31
DOI: 10.21037/atm-2026-0046 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Annals of Translational Medicine, 2026-06. Verfasst von Frantisek Zitricky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
- Center for Primary Health Care Research, Lund University, Malmö, Sweden.
- University Clinic Primary Care Skåne, Region Skåne, Sweden.
- Department of Family and Community Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA.
- Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
- Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
ORCID-Profile: Kari Hemminki
Zitieren
APA
Zitricky, F., Sundquist, K., Sundquist, J., Försti, A., Hemminki, A., Kaaks, R., & Hemminki, K. (2026). Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden. Annals of Translational Medicine, 14(3), 31-31. https://doi.org/10.21037/atm-2026-0046
Vancouver
Zitricky F, Sundquist K, Sundquist J, Försti A, Hemminki A, Kaaks R, et al. Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden. Annals of Translational Medicine. 2026;14(3):31-31. doi:10.21037/atm-2026-0046
BibTeX
@article{Zitricky2026,
author = {Zitricky, Frantisek and Sundquist, Kristina and Sundquist, Jan and Försti, Asta and Hemminki, Akseli and Kaaks, Rudolf and Hemminki, Kari},
title = {Does lung adenocarcinoma subtyping offer clinical benefits?—a retrospective population-based cohort study from Sweden},
journal = {Annals of Translational Medicine},
year = {2026},
volume = {14},
number = {3},
pages = {31--31},
doi = {10.21037/atm-2026-0046}
}
EUVIMED